Gene · 10371
Papers3,028
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,028
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel and recurrent genetic variants associated with male and female infertility. | J Appl Genet | 2025 | 39809967 | PubTator, text mining | PubMed |
| Inhibition of RIPK1-driven necroptosis ameliorates inflammatory hyperalgesia caused by lipopolysaccharide: involvement of TLR-, NLRP3-, and caspase-11-mediated signaling pathways. | Cell Mol Biol (Noisy-le-grand) | 2025 | 39799497 | PubTator, text mining | PubMed |
| Superoxide dismutase 2 deficiency in mesenchymal stromal cells induces sympathetic denervation and functional impairment of brown adipose tissue. | Pathol Int | 2025 | 39760485 | PubTator, text mining | PubMed |
| Plexins: Navigating through the neural regulation and brain pathology. | Neurosci Biobehav Rev | 2025 | 39756719 | PubTator, text mining | PubMed |
| Neuronal guidance factor Sema3A inhibits neurite ingrowth and prevents chondrocyte hypertrophy in the degeneration of knee cartilage in mice, monkeys and humans. | Bone Res | 2025 | 39746903 | PubTator, text mining | PubMed |
| The Role of the Axonal Guidance Cue Semaphorin 3A in Innervation of the Postnatal Heart in Health and Disease. | Can J Cardiol | 2025 | 39746509 | PubTator, text mining | PubMed |
| Semaphorins and its receptors: Emerging cellular biomarkers and therapeutic targets in autoimmune and inflammatory disorders. | Life Sci | 2025 | 39608445 | PubTator, text mining | PubMed |
| Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing. | Neuro Oncol | 2025 | 39383211 | PubTator, text mining | PubMed |
| SEMA3A as a biomarker of primary ventricular fibrillation complicating STEMI. | Heart Rhythm | 2025 | 39187142 | PubTator, text mining | PubMed |
| A Study on Semaphorin 3A Level in Juvenile-onset Systemic Lupus Erythematosus Patients. | Curr Rheumatol Rev | 2025 | 39034724 | PubTator, text mining | PubMed |
| CircZNF609 sponges miR-135b to up-regulate SEMA3A expression to alleviate ox-LDL-induced atherosclerosis. | Mol Cell Biochem | 2025 | 38819599 | PubTator, text mining | PubMed |
| Sema3A Affect Osteolytic Bone Metastasis of Non-small Cell Lung Cancer. | Recent Pat Anticancer Drug Discov | 2025 | 38629364 | PubTator, text mining | PubMed |
| The Role of Immune Semaphorins in Sepsis-A Prospective Cohort Study. | Microorganisms | 2024 | 39770766 | PubTator, text mining | PubMed |
| A targetable developmental program co-regulates angiogenesis and immune evasion. | bioRxiv | 2024 | 39764043 | PubTator, text mining | PubMed |
| Biomechanical Finite Element Analysis of Two Types of Short-Angled Implants Across Various Bone Classifications. | Materials (Basel) | 2024 | 39685119 | PubTator, text mining | PubMed |
| [Semaphorin-3A signaling decreases the porosity of sinusoidal endothelial cells in steatotic liver diseases]. | Med Sci (Paris) | 2024 | 39656975 | PubTator, text mining | PubMed |
| Characteristics of gene expression in epicardial adipose tissue and subcutaneous adipose tissue in patients at risk for heart failure undergoing coronary artery bypass grafting. | BMC Genomics | 2024 | 39375631 | PubTator, text mining | PubMed |
| Macrophage polarization and macrophage-related factor expression in hypertrophy of the ligamentum flavum. | Eur Spine J | 2024 | 39375228 | PubTator, text mining | PubMed |
| Adriamycin-induced podocyte injury via the Sema3A/TRPC5/Rac1 pathway. | Front Med (Lausanne) | 2024 | 39301490 | PubTator, text mining | PubMed |
| Areal specializations in the morpho-electric and transcriptomic properties of primate layer 5 extratelencephalic projection neurons. | Cell Rep | 2024 | 39277859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10371/papers?page=7